From the heart: Imaging at ACC.15

Tomorrow in San Diego, thousands will gather to kick off the start of the American College of Cardiology’s Annual Scientific Session & Expo, which runs from March 14 – 16. Cutting-edge imaging in the cardiology space will be on display throughout the conference, from the late-breaking trials to the educational sessions.

Whether you’ll be in attendance or following from home, you’ll want to pay attention to the results of the PROMISE trial (PROspective Multicenter Imaging Study for Evaluation of chest pain) as researchers unveil results from their study comparing anatomic and functional diagnostic testing for chest pain. Also of interest is the work of Adel Allam, MD, from Al-Azhar University in Cairo, and colleagues, who have used CT on mummies to track heart disease across time. For a preview, check out Health Imaging’s past coverage of a paper from Allam et al here.

These topics and a few other imaging-specific highlights are outlined in the slide show below.

For live coverage of all ACC.15 has to offer, be sure to follow the reports from our sister publication Cardiovascular Business (and on Twitter by following @CardioBusiness). And keep an eye on the Health Imaging newsletter next week as we bring you the top stories in imaging at ACC.15 and beyond.

Imaging at ACC.15: Session Spotlight from Trimed Media Group

 

-Evan Godt
Editor – Health Imaging

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.